JP2001508773A5 - - Google Patents

Download PDF

Info

Publication number
JP2001508773A5
JP2001508773A5 JP1998530802A JP53080298A JP2001508773A5 JP 2001508773 A5 JP2001508773 A5 JP 2001508773A5 JP 1998530802 A JP1998530802 A JP 1998530802A JP 53080298 A JP53080298 A JP 53080298A JP 2001508773 A5 JP2001508773 A5 JP 2001508773A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998530802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001508773A (ja
Filing date
Publication date
Priority claimed from SE9700061A external-priority patent/SE511313C2/sv
Application filed filed Critical
Publication of JP2001508773A publication Critical patent/JP2001508773A/ja
Publication of JP2001508773A5 publication Critical patent/JP2001508773A5/ja
Ceased legal-status Critical Current

Links

JP53080298A 1997-01-13 1998-01-08 徐放性組成物 Ceased JP2001508773A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
SE9700061-6 1997-01-13
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (2)

Publication Number Publication Date
JP2001508773A JP2001508773A (ja) 2001-07-03
JP2001508773A5 true JP2001508773A5 (cg-RX-API-DMAC7.html) 2005-09-08

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53080298A Ceased JP2001508773A (ja) 1997-01-13 1998-01-08 徐放性組成物

Country Status (9)

Country Link
US (1) US6660278B1 (cg-RX-API-DMAC7.html)
EP (1) EP0954287B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001508773A (cg-RX-API-DMAC7.html)
AT (1) ATE243024T1 (cg-RX-API-DMAC7.html)
AU (1) AU5583298A (cg-RX-API-DMAC7.html)
CA (1) CA2277377C (cg-RX-API-DMAC7.html)
DE (1) DE69815659T2 (cg-RX-API-DMAC7.html)
SE (1) SE511313C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998030206A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
AU2002335077B2 (en) * 2001-10-19 2006-09-07 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
NZ551990A (en) 2004-06-04 2011-01-28 Camurus Ab Liquid depot formulations
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006037049A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Application of a coating on a medical device
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
EP1933991A4 (en) 2005-10-15 2012-05-02 Atrium Medical Corp HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS
EP2626091B1 (en) 2006-11-06 2016-09-28 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2393472B1 (en) 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
KR101663551B1 (ko) * 2010-05-18 2016-10-07 후지필름 가부시키가이샤 카로티노이드 함유 조성물 및 그 제조 방법
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
ES2837803T3 (es) 2012-07-26 2021-07-01 Camurus Ab Formulaciones de opioides
EP2877155B1 (en) 2012-07-26 2020-10-28 Camurus AB Opioid formulations
CN111432805B (zh) 2017-11-27 2023-02-17 梅克里内科尼蒂翁公司 3α-乙炔基-3β-羟基雄甾烷-17-酮肟的药物制剂
JP7598313B2 (ja) 2018-04-26 2024-12-11 ナノメッド ホールディングス プロプライエタリー リミテッド ジェムシタビン両親媒性プロドラッグ
US12194014B2 (en) 2018-06-21 2025-01-14 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
EP4284182A1 (de) * 2021-01-29 2023-12-06 IOI Oleo GmbH Polyglycerolfettsäureesterhaltige zusammensetzung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (cg-RX-API-DMAC7.html) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Similar Documents

Publication Publication Date Title
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2000509635A5 (cg-RX-API-DMAC7.html)
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000509942A5 (cg-RX-API-DMAC7.html)
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2001511255A5 (cg-RX-API-DMAC7.html)
JP2000509587A5 (cg-RX-API-DMAC7.html)
JP2000507369A5 (cg-RX-API-DMAC7.html)
JP2000507433A5 (cg-RX-API-DMAC7.html)
JP2000508866A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508022A5 (cg-RX-API-DMAC7.html)
JP2000508841A5 (cg-RX-API-DMAC7.html)
JP2002507235A5 (cg-RX-API-DMAC7.html)
JP2001524253A5 (cg-RX-API-DMAC7.html)
JP2001508773A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2000509804A5 (cg-RX-API-DMAC7.html)
JP2000509755A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2000510247A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2000508836A5 (cg-RX-API-DMAC7.html)
JP2000509520A5 (cg-RX-API-DMAC7.html)
JP2000509818A5 (cg-RX-API-DMAC7.html)